Mobia Medical, Inc. MOBI
11.28 USD +0.04 (+0.36%)
At closeNov 6, 2026, 7:09 AM EST
11.22 -0.06 -0.53%
Pre-market · Nov 6, 7:09 AM ET
10.78 Day range 11.84
8.03 52-week range 15.29
- YTD
- -4.00%
- 1 year
- -4.00%
- Market cap
- 375.52M
- EPS (ttm)
- -2.96
- YTD return
- -4.00%
- 1-year return
- -4.00%
- Volume
- 183.26K
- Avg volume
- 206.19K
- Open
- 11.07
- Previous close
- 11.24
- Day's range
- 10.78 – 11.84
- 52-week range
- 8.03 – 15.29
YTD -0.47 (-4.00%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Financials — quick view
MOBI Revenue — quarterly 13.51M
MOBI Net income — quarterly -21.04M
MOBI EPS — quarterly -1.10
News
What Mobia Medical (MOBI) Said on Its Q3 Earnings Call 
Sky-mobi Q3 2026 Earnings Call Transcript 
Mobia Medical Raises FY2026 Sales Guidance from $54.000M-$56.000M to $57.000M-$57.500M vs $55.030M Est 
Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference 
Gap Posts Upbeat Q2 Earnings, Joins Solstice Advanced Materials, N-Able And Other Big Stocks Moving Higher On Friday 
JP Morgan Maintains Overweight on Mobia Medical, Raises Price Target to $17 - Mobia Medical Sees FY2026 Sales $54.000M-$56.000M vs $53.504M Est
Mobia Medical Q2 EPS $(1.10) Misses $(0.82) Estimate, Sales $13.505M Beat $12.380M Estimate 
Mobia Medical Announces Publication Of 2-Yr Follow-Up Data From VNS-REHAB Study In Neurology, Official Peer-Reviewed Journal Of American Academy Of Neurology - Mobia Medical Says CMS Proposes To Maintain Vivistim CPT Code 64568 Under New Technology APC 1580 With ~$45,000 Outpatient Payment Rate For 2027
Your note
Sign in to keep a note on MOBI — it syncs with the Stock Master app.